Literature DB >> 26746186

A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis.

Hans-Peter Müller1, Martin R Turner2, Julian Grosskreutz3, Sharon Abrahams4, Peter Bede5, Varan Govind6, Johannes Prudlo7, Albert C Ludolph1, Massimo Filippi8, Jan Kassubek1.   

Abstract

OBJECTIVE: Damage to the cerebral tissue structural connectivity associated with amyotrophic lateral sclerosis (ALS), which extends beyond the motor pathways, can be visualised by diffusion tensor imaging (DTI). The effective translation of DTI metrics as biomarker requires its application across multiple MRI scanners and patient cohorts. A multicentre study was undertaken to assess structural connectivity in ALS within a large sample size.
METHODS: 442 DTI data sets from patients with ALS (N=253) and controls (N=189) were collected for this retrospective study, from eight international ALS-specialist clinic sites. Equipment and DTI protocols varied across the centres. Fractional anisotropy (FA) maps of the control participants were used to establish correction matrices to pool data, and correction algorithms were applied to the FA maps of the control and ALS patient groups.
RESULTS: Analysis of data pooled from all centres, using whole-brain-based statistical analysis of FA maps, confirmed the most significant alterations in the corticospinal tracts, and captured additional significant white matter tract changes in the frontal lobe, brainstem and hippocampal regions of the ALS group that coincided with postmortem neuropathological stages. Stratification of the ALS group for disease severity (ALS functional rating scale) confirmed these findings.
INTERPRETATION: This large-scale study overcomes the challenges associated with processing and analysis of multiplatform, multicentre DTI data, and effectively demonstrates the anatomical fingerprint patterns of changes in a DTI metric that reflect distinct ALS disease stages. This success paves the way for the use of DTI-based metrics as read-out in natural history, prognostic stratification and multisite disease-modifying studies in ALS. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26746186     DOI: 10.1136/jnnp-2015-311952

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  63 in total

Review 1.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

Review 2.  Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.

Authors:  Maria Pia Sormani; Matteo Pardini
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

3.  Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.

Authors:  Barbara Commisso; Lingjun Ding; Karl Varadi; Martin Gorges; David Bayer; Tobias M Boeckers; Albert C Ludolph; Jan Kassubek; Oliver J Müller; Francesco Roselli
Journal:  Elife       Date:  2018-08-23       Impact factor: 8.140

4.  Radial diffusivity as an imaging biomarker for early diagnosis of non-demented amyotrophic lateral sclerosis.

Authors:  Yifang Bao; Liqin Yang; Yan Chen; Biyun Zhang; Haiqing Li; Weijun Tang; Daoying Geng; Yuxin Li
Journal:  Eur Radiol       Date:  2018-06-08       Impact factor: 5.315

Review 5.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

6.  Corticoefferent pathways in pure lower motor neuron disease: a diffusion tensor imaging study.

Authors:  Angela Rosenbohm; Hans-Peter Müller; Annemarie Hübers; Albert C Ludolph; Jan Kassubek
Journal:  J Neurol       Date:  2016-09-13       Impact factor: 4.849

7.  Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS).

Authors:  Sneha Chenji; Abdullah Ishaque; Dennell Mah; Esther Fujiwara; Christian Beaulieu; Peter Seres; Simon J Graham; Richard Frayne; Lorne Zinman; Angela Genge; Lawrence Korngut; Wendy Johnston; Sanjay Kalra
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

8.  UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis.

Authors:  Katerina Placek; G Michael Baer; Lauren Elman; Leo McCluskey; Laura Hennessy; Pilar M Ferraro; Edward B Lee; Virginia M Y Lee; John Q Trojanowski; Vivianna M Van Deerlin; Murray Grossman; David J Irwin; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-09-27       Impact factor: 4.673

9.  Intuitive Staging Correlates With King's Clinical Stage.

Authors:  Ahmad Al Khleifat; Rubika Balendra; Ton Fang; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2021-04-06       Impact factor: 4.092

10.  A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS.

Authors:  Sanjay Kalra; Hans-Peter Müller; Abdullah Ishaque; Lorne Zinman; Lawrence Korngut; Angela Genge; Christian Beaulieu; Richard Frayne; Simon J Graham; Jan Kassubek
Journal:  Neurology       Date:  2020-07-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.